Multi-Arterial Grafting Inches Upward in Surgeon Adoption Learning curve holds strong in CABG technique Jan 30, 2022
ECG Monitoring for Post-TAVR Delayed Conduction Disturbances Put to the Test How long should monitoring last, and in whom? Dec 20, 2021
Bentracimab on Point as Fast-Acting Ticagrelor Reversal Agent "Immediate and sustained" benefit, interim REVERSE-IT analysis found Nov 17, 2021
PALACS: A Win for Posterior Left Pericardiotomy for Post-Op Afib Trial offers good news for patients getting coronary, aortic valve, and aortic surgeries Nov 14, 2021
Tricuspid Repair Boosts Mitral Valve Surgery Outcomes Randomized trial supports combined surgery for moderate regurgitation Nov 13, 2021
Delaying Surgery Hurts Patients With Silent Aortic Stenosis Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
DCBs for the Coronaries: Early Victories for New Drug Coatings Researchers eye next gen drug-coated balloons despite lack of FDA OK for use in PCI Nov 07, 2021
Gastrointestinal Damage Nearly Universal With Antiplatelet Use After PCI Noninvasive endoscopy in OPT-PEACE reveals surprises about GI effects of antiplatelets Nov 07, 2021
Longstanding Vascular Closure Technique Triumphs Over Collagen Plug Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
TAVR Chugging Along at 5 Years in SURTAVI Trial Plus, data suggest that it is probably cost-effective in low-risk patients Nov 06, 2021
TAVR Operators Divided on Need for Bicuspid RCT Odds of a study coming to fruition are low Nov 05, 2021
Surgery Keeps Edge Over Contemporary Stenting for Multivessel CAD Large noninferiority margin still not enough in FAME 3 trial Nov 04, 2021
Signs Point to Half-Dose DOAC Route After Watchman Procedure Search continues for best antithrombotic strategy after LAA closure Oct 13, 2021
Study: Kids Exposed to Harmful Plastics During Heart Surgery Are tubing and blood bags sources of trouble? Oct 09, 2021
Post-TAVR Pacemakers Not All Doom and Gloom A bit of reassurance from Swedish cohort study Oct 04, 2021
Radiation or Surgery in Early Lung Cancer: Does It Make a Difference? Ablative radiation still noninferior to VATS after longer follow-up Sep 24, 2021
Low Risk and Bicuspid Anatomy: A Passable Combination for TAVR Thus Far Clinical outcomes not worse compared with tricuspid TAVR Sep 21, 2021
Better Late Than Never for Revascularization in STEMI Favorable outcomes for latecomers presenting up to 2 days after symptom onset Sep 20, 2021
More Data in Support of Surgery for Malignant Pleural Mesothelioma Six-month improvement in overall survival with surgery plus chemotherapy versus chemo alone Sep 13, 2021
Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesothelioma Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
LAA Occluder Opens Doors to Patients Who Can't Tolerate Blood Thinners Even Briefly The Amulet IDE trial that led to Amplatzer Amulet's FDA approval Aug 30, 2021
Edoxaban: A Mixed Bag for TAVR Patients Needing Anticoagulation Weighing positive efficacy data against excess GI bleeds Aug 28, 2021
Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. There is a different approach to deciding the suitability of TAVR, however Aug 28, 2021
Are Hemoglobin Cutoffs for Anemia Outdated? A growing call for WHO criteria to be tightened Aug 06, 2021
TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
Urine Tests Before Surgery Blasted as Mostly Unnecessary Abundance of caution is way overdone, researchers suggest Aug 02, 2021
Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery Observational study suggests excess readmissions with less invasive procedure Jul 23, 2021
Watchman FLX Stays on Track for Stroke Prevention Next-generation LAA occluder maintains good results at 2 years Jul 22, 2021
Does COAPT Change the Need to Try Foundational HF Drugs in Functional MR? Current GDMT titration approach under fire during TVT debate Jul 21, 2021
After Some Early Successes for Bicuspid TAVR, a Randomized Trial May Be Unlikely Are observational data on highly selected patients good enough? Jul 21, 2021
FDA Breaks New Ground With Transplant Drug Approval No prospective trial offered or required Jul 19, 2021
Scarring on an Otherwise Normal Heart: Reassuring Data Emerge Phenomenon tied to very low burden of major arrhythmic events Jul 14, 2021
Trouble Looms With Pacemakers After Aortic Valve Replacement Permanent pacemaker implantation of clinical significance in cohort study Jul 13, 2021
FDA Piles on New Warnings for Blood Volume Expanders Hydroxyethyl starch products shouldn't be used for low blood volume unless no other options exist Jul 09, 2021
Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
Regenerative Therapy Makes Headway in HF ... in the Right Patients Study of autologous skeletal cell-patch implantation in Japan Jul 02, 2021
Medtronic's LVAD Pulled From Market Due to Neurological, Mortality Risks Physicians must stop implanting the HeartWare system, says FDA Jun 03, 2021
Passing Early-Term Report Cards for New Mitral, Tricuspid Valve Interventions A glance at devices coming down the structural heart pipeline in the coming years May 24, 2021
Navitor Shuts Out Leaky TAVR, but Pacemaker Rates a Concern? 30-day data for a new version of the Portico valve May 20, 2021
